Skip to main content
Fig. 4 | Critical Care

Fig. 4

From: Auxora versus standard of care for the treatment of severe or critical COVID-19 pneumonia: results from a randomized controlled trial

Fig. 4

Eight-point ordinal scale over time in patients with severe COVID-19 pneumonia. The mean difference was statistically significant for Auxora (n = 17) when compared with standard of care (n = 9) at day 6 and days 9 through 12 (*P < 0.05 versus standard of care). Patients with severe COVID-19 pneumonia were receiving low-flow supplemental oxygen (arm A)

Back to article page
\